ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ALXO ALX Oncology Holdings Inc

16,12
-0,50 (-3,01%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:14:51
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ALX Oncology Holdings Inc ALXO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,50 -3,01% 16,12 22:14:51
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
16,92 15,2144 17,13 15,34 16,62
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202415:00GLOBEALX Oncology Announces Initiation of Phase 2..
24.4.202416:00GLOBEALX Oncology Announces Two Evorpacept Abstracts Accepted for..
09.4.202423:30GLOBEALX Oncology Reports Encouraging Clinical Data of Evorpacept..
07.3.202422:05EDGAR2Form 8-K - Current report
07.3.202422:03GLOBEALX Oncology Reports Fourth Quarter and Full Year 2023..
05.3.202422:30GLOBEALX Oncology Announces Two Evorpacept Clinical Abstracts..
17.2.202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202400:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202414:00GLOBEALX Oncology to Present at the 42nd Annual J.P. Morgan..
26.12.202322:01EDGAR2Form 8-K - Current report
13.11.202322:05GLOBEALX Oncology Reports Third Quarter 2023 Financial Results..
13.11.202322:03EDGAR2Form 8-K - Current report
01.11.202321:05GLOBEALX Oncology Announces November Investor Conference..
10.10.202322:05GLOBEALX Oncology Announces Closing of Public Offering, Including..
06.10.202312:06EDGAR2Form 8-K - Current report
06.10.202312:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05.10.202314:00GLOBEALX Oncology Announces Pricing of Public Offering
04.10.202323:21EDGAR2Form 8-K - Current report
04.10.202323:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04.10.202322:10GLOBEALX Oncology Announces Proposed Public Offering
04.10.202314:00EDGAR2Form 8-K - Current report
03.10.202316:03IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
03.10.202312:00GLOBEALX Oncology Reports Positive Interim Phase 2 ASPEN-06..
02.10.202322:05GLOBEALX Oncology to Host Investor Call and Webcast on October 3,..
20.9.202314:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
11.9.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08.9.202322:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06.9.202322:05EDGAR2Form 8-K - Current report
06.9.202314:00GLOBEALX Oncology Realigns Executive Leadership Team
01.9.202322:11EDGAR2Form S-3 - Registration statement under Securities Act of..
31.8.202313:00GLOBEALX Oncology Announces September Investor Conference..
25.8.202322:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10.8.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202322:05EDGAR2Form 8-K - Current report
10.8.202322:01GLOBEALX Oncology Reports Second Quarter 2023 Financial Results..
27.7.202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.7.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.7.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.7.202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.6.202313:00GLOBEALX Oncology Receives Orphan Drug Designation from the..
11.5.202322:01GLOBEALX Oncology Reports First Quarter 2023 Financial Results..
09.5.202313:00GLOBEALX Oncology Announces First Patient Dosed in Phase 2..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock